Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.36 Million AUD | 31.61% |
| 2022 | 12.7 Million AUD | 43.2% |
| 2021 | 8.87 Million AUD | 11.5% |
| 2020 | 7.95 Million AUD | 35.29% |
| 2019 | 5.88 Million AUD | -35.72% |
| 2018 | 9.14 Million AUD | 27.1% |
| 2017 | 7.19 Million AUD | -42.02% |
| 2016 | 12.41 Million AUD | 200.54% |
| 2015 | 4.13 Million AUD | 77.61% |
| 2014 | 2.32 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 16.71 Million AUD | 31.61% |
| 2023 Q2 | 2.88 Million AUD | 0.0% |
| 2023 Q1 | 2.88 Million AUD | 17.24% |
| 2023 Q4 | 2.75 Million AUD | 0.0% |
| 2023 Q3 | 2.75 Million AUD | -4.48% |
| 2022 Q4 | 2.45 Million AUD | 0.0% |
| 2022 FY | 12.7 Million AUD | 43.2% |
| 2022 Q3 | 2.45 Million AUD | 18.01% |
| 2022 Q2 | 2.08 Million AUD | 0.0% |
| 2022 Q1 | 2.08 Million AUD | 37.66% |
| 2021 Q3 | 1.51 Million AUD | -3.57% |
| 2021 Q4 | 1.51 Million AUD | 0.0% |
| 2021 FY | 8.87 Million AUD | 11.5% |
| 2021 Q2 | 1.57 Million AUD | 0.0% |
| 2021 Q1 | 1.57 Million AUD | 13.11% |
| 2020 Q1 | 1.19 Million AUD | 40.34% |
| 2020 Q2 | 1.19 Million AUD | 0.0% |
| 2020 Q4 | 1.38 Million AUD | 0.0% |
| 2020 FY | 7.95 Million AUD | 35.29% |
| 2020 Q3 | 1.38 Million AUD | 16.65% |
| 2019 Q1 | 974.21 Thousand AUD | -16.01% |
| 2019 FY | 5.88 Million AUD | -35.72% |
| 2019 Q3 | 847.95 Thousand AUD | -12.96% |
| 2019 Q2 | 974.21 Thousand AUD | 0.0% |
| 2019 Q4 | 847.95 Thousand AUD | 0.0% |
| 2018 Q2 | 1.54 Million AUD | 0.0% |
| 2018 FY | 9.14 Million AUD | 27.1% |
| 2018 Q3 | 1.15 Million AUD | -24.88% |
| 2018 Q1 | 1.54 Million AUD | 7.16% |
| 2018 Q4 | 1.15 Million AUD | 0.0% |
| 2017 FY | 7.19 Million AUD | -42.02% |
| 2017 Q3 | 1.44 Million AUD | -34.4% |
| 2017 Q4 | 1.44 Million AUD | 0.0% |
| 2017 Q2 | 2.19 Million AUD | -0.0% |
| 2017 Q1 | 2.19 Million AUD | 0.0% |
| 2016 FY | 12.41 Million AUD | 200.54% |
| 2015 FY | 4.13 Million AUD | 77.61% |
| 2014 FY | 2.32 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -30.36% |
| Arrayit Corporation | 6.19 Million USD | 77.935% |
| Atlantic International Corp. | 5.57 Million USD | 75.486% |
| Biocept, Inc. | 29.4 Million USD | 95.349% |
| Bioqual, Inc. | 7.44 Million USD | 81.642% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -77.102% |
| DermTech, Inc. | 104.01 Million USD | 98.685% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 99.179% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 93.956% |
| iMD Companies, Inc. | 151.8 Thousand USD | -800.788% |
| IDenta Corp. | 662.97 Thousand USD | -106.264% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 93.241% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -3417.083% |
| InVitro International | 661.32 Thousand USD | -106.779% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 80.734% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -2253.175% |
| Medical Imaging Corp. | 1.91 Million USD | 28.485% |
| NovelStem International Corp. | 3.53 Million USD | 61.347% |
| Optigenex Inc. | 1.28 Million USD | -6.181% |
| PharmChem, Inc. | 2.93 Million USD | 53.348% |
| Proteome Sciences plc | 3.26 Million USD | 58.156% |
| Response Genetics, Inc | 25.31 Million USD | 94.599% |
| Rennova Health, Inc. | 7.67 Million USD | 82.189% |
| RushNet, Inc. | 1.78 Million USD | 23.576% |
| ScreenPro Security Inc. | 3.23 Million USD | 57.78% |
| Stella Diagnostics Inc. | 11.42 Million USD | 88.033% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 81.377% |
| Todos Medical Ltd. | 14.05 Million USD | 90.273% |